Skip to main content
Changes in depression subtypes for women during treatment with citalopram: a latent transition analysis
University of Massachusetts Medical School Faculty Publications
  • Christine M. Ulbricht, University of Massachusetts Medical School
  • Levent Dumenci, Temple University
  • Anthony J. Rothschild, University of Massachusetts Medical School
  • Kate L. Lapane, University of Massachusetts Medical School
UMMS Affiliation
Department of Quantitative Health Sciences; Department of Psychiatry
Publication Date
Document Type

The aim of this study was to characterize latent subtypes of major depression and changes in these subtypes among women receiving citalopram in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Latent transition analysis was applied to data from 755 women who completed baseline and week 12 study visits in level 1 of STAR*D. Items from the self-report version of the Quick Inventory of Depressive Symptomatology were used as indicators of latent depression subtype. Four subtypes were identified at baseline and week 12. The baseline subtypes were Mild (21 %), Moderate (30 %), Severe with Increased Appetite (16 %), and Severe with Decreased Appetite (34 %). The subtypes at week 12 were Symptom Resolution (65 %), Mild (23 %), Moderate (9 %), and Severe with Psychomotor Disturbances (3 %). Women in the Moderate subtype at baseline had the greatest chance of moving to Symptom Resolution (87 %). Women in the Severe with Decreased Appetite subtype had the lowest chance of transitioning to Symptom Resolution (46 %). Depression severity and appetite distinguished depression subtypes for women before treatment with citalopram. Depression severity and psychomotor disturbances characterized the subtypes after treatment. This work highlights the need to consider how depression treatment changes different symptoms instead of relying exclusively on summary rating scores.


  • Appetite,
  • Major depressive disorder,
  • Person-centered analysis,
  • Psychomotor disturbances,
  • Sex differences
DOI of Published Version
Arch Womens Ment Health. 2016 Oct;19(5):769-78. doi: 10.1007/s00737-016-0606-8. Epub 2016 Jan 22. Link to article on publisher's site
Related Resources
Link to Article in PubMed
PubMed ID
Citation Information
Christine M. Ulbricht, Levent Dumenci, Anthony J. Rothschild and Kate L. Lapane. "Changes in depression subtypes for women during treatment with citalopram: a latent transition analysis" Vol. 19 Iss. 5 (2016) ISSN: 1434-1816 (Linking)
Available at: